Hemophilia A, Congenital  >>  Optivate (factor VIII/von Willebrand factor)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Optivate (factor VIII/von Willebrand factor) / Bio Products Lab
NCT02250482: An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.

Completed
3
Europe
Optivate® (Human Coagulation Factor VIII)
Bio Products Laboratory
Haemophilia A
08/03
 
NCT02246881: A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.

Completed
3
Europe
Optivate® (Human Coagulation Factor VIII)
Bio Products Laboratory
Von Willebrand Disease
01/04
 
NCT02246868: An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.

Completed
3
Europe
Optivate® (Human Coagulation Factor VIII)
Bio Products Laboratory
Haemophilia A
08/04
 
NCT02246894: A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.

Completed
3
Europe
Optivate® (Human Coagulation Factor VIII)
Bio Products Laboratory
Haemophilia A
01/05
 

Download Options